BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$661M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$506M |
| 3 |
Industrial Select Sector SPDR Fund
XLI
|
+$504M |
| 4 |
DuPont de Nemours
DD
|
+$350M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$333M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$356M |
| 2 |
Linde
LIN
|
+$339M |
| 3 |
Visa
V
|
+$276M |
| 4 |
Apple
AAPL
|
+$207M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$184M |
Sector Composition
| 1 | Technology | 19.78% |
| 2 | Healthcare | 12.42% |
| 3 | Consumer Discretionary | 9.92% |
| 4 | Financials | 8.42% |
| 5 | Industrials | 5.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Brookfield Renewable
BEP
$7.14B
| $226K | ﹤0.01% |
7,180
+4,787
| +200% | +$151K |
|
2352
TETRA Technologies
TTI
$640M
| $226K | ﹤0.01% |
85,202
+51,893
| +156% | +$138K |
|
2353
Artivion
AORT
$1.94B
| $226K | ﹤0.01% |
17,227
+10,387
| +152% | +$136K |
|
2354
Shore Bancshares
SHBI
$567M
| $225K | ﹤0.01% |
15,728
+13,112
| +501% | +$187K |
|
2355
Rimini Street
RMNI
$414M
| $224K | ﹤0.01% |
54,337
+27,278
| +101% | +$112K |
|
2356
Business First Bancshares
BFST
$729M
| $224K | ﹤0.01% |
13,049
+7,698
| +144% | +$132K |
|
2357
Global X Autonomous & Electric Vehicles ETF
DRIV
$344M
| $223K | ﹤0.01% |
9,350
+2,684
| +40% | +$64K |
|
2358
SPDR S&P Pharmaceuticals ETF
XPH
$188M
| $222K | ﹤0.01% |
5,405
+677
| +14% | +$27.8K |
|
|
VRNA
2359
Verona Pharma
VRNA
$9.2B
| $221K | ﹤0.01% |
10,982
+10,560
| +2,502% | +$212K |
|
2360
Atlanta Braves Holdings Series A
BATRA
$2.84B
| $220K | ﹤0.01% |
6,368
+5,635
| +769% | +$195K |
|
2361
Liquidity Services
LQDT
$845M
| $219K | ﹤0.01% |
16,633
+552
| +3% | +$7.27K |
|
|
VRAY
2362
DELISTED
ViewRay, Inc.
VRAY
| $218K | ﹤0.01% |
62,942
+40,038
| +175% | +$139K |
|
2363
Surmodics
SRDX
$459M
| $216K | ﹤0.01% |
9,499
+7,251
| +323% | +$165K |
|
2364
Phibro Animal Health
PAHC
$1.67B
| $215K | ﹤0.01% |
14,033
+5,084
| +57% | +$77.9K |
|
2365
Perrigo
PRGO
$3.04B
| $214K | ﹤0.01% |
5,974
-37,920
| -86% | -$1.36M |
|
2366
Home Bancorp
HBCP
$437M
| $214K | ﹤0.01% |
6,484
+3,353
| +107% | +$111K |
|
2367
Innoviva
INVA
$1.25B
| $214K | ﹤0.01% |
18,985
+13,878
| +272% | +$156K |
|
2368
Crawford & Co Class A
CRD.A
$513M
| $213K | ﹤0.01% |
25,476
+20,888
| +455% | +$175K |
|
2369
Silvercrest Asset Management
SAMG
$134M
| $212K | ﹤0.01% |
11,655
+5,102
| +78% | +$92.8K |
|
2370
iShares MSCI United Kingdom ETF
EWU
$2.95B
| $212K | ﹤0.01% |
6,562
+4,485
| +216% | +$145K |
|
2371
Rayonier
RYN
$4.04B
| $211K | ﹤0.01% |
6,668
-23,246
| -78% | -$736K |
|
2372
TruBridge
TBRG
$299M
| $211K | ﹤0.01% |
6,981
-2,081
| -23% | -$62.8K |
|
2373
Capital City Bank Group
CCBG
$737M
| $209K | ﹤0.01% |
7,145
+1,516
| +27% | +$44.4K |
|
2374
Dorchester Minerals
DMLP
$1.2B
| $208K | ﹤0.01% |
6,881
+2,871
| +72% | +$87K |
|
2375
Theravance Biopharma
TBPH
$687M
| $208K | ﹤0.01% |
19,204
-24,397
| -56% | -$265K |
|